Biomunex Pharmaceuticals will showcase its MAIT Engager Platform during the 11th Annual ...

Biomunex Pharmaceuticals, a biopharmaceutical company specializing in the development of next generation immunotherapies based on the discovery and development of bispecific and multispecific ...
PharmiWeb

Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T ...

SEATTLE, WASHINGTON / ACCESS Newswire / June 20, 2025 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel ...